Conference Calls and Earnings Call Transcripts for NSE and BSE Stocks - Q1FY22

Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans - Q1FY22

announcement
Conference/Earnings Calls Alerts
423.60
1.80%
3128.60
1.18%
MAHINDRA & MAHINDRA LTD. - 500520 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …
BSE India
This is further to our letter bearing REF:NS:SEC dated 24th June, 2022 wherein we had given you an advance intimation about the Company participating in a Non-Deal Road Show (NDR) with Several Funds/Investors in New York on 28th - 29th June, 2022. In this regard we would like to mention that the Presentation(s) which was sent to the Stock Exchanges vide letter bearing REF:NS:SEC dated 30th May, 2022 and which is available at the Weblink:https://www.mahindra.com/resources/investorreports/ FY22/Earnings%20Update/MM-Annual-Analyst-Meet-2022-Presentations-deck-30th- May-2022.pdf would be made at the NDR. In addition to the above, a Presentation, which is enclosed, would also be made and shared during the NDR. The same is also being uploaded on the Company's website and can be accessed at the Weblink:https://www.mahindra.com/resources/investorreports/ FY23/Events%20Update/Investor-Deck-NDR-June-28-29-2022.pdf
881.00
1.54%
INDUSIND BANK LTD. - 532187 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Sub: Allotment of shares under the Company's Employee Stock Option Scheme Ref: IndusInd Bank Limited This is to inform that the company has allotted 1,02,196 (One Lakh Two Thousand One Hundred Ninety Six) Equity Shares of Rs.10/- (Rupees Ten Only) each on June 27, 2022 to those grantees who had exercised their option under the Company's Employee Stock Option Scheme. The said shares will rank pari-passu with the existing shares of the Company in all respect. Please take the above on record and upload this announcement on the website of the Exchange.
451.80
1.92%
1647.60
6.65%
1260.90
0.82%

Investor Day with Dr. Reddy's Laboratories Management, Investors and Analysts on FY22 Performance and Outlook. Click pdf to read the full transcript.

Management in attendance:

G V Prasad – Co-Chairman & Managing Director

Erez Israeli – Chief Executive Officer

Parag Agarwal – Chief Financial Officer

MV Ramana – Chief Executive Officer, Branded Markets

Sanjay Sharma – Global Head of Manufacturing

Archana Bhaskar – Chief Human Resources Officer

Jayanth Sridhar – Global Head of Biologics

Amit Agarwal – Head of Investor Relations & Analytics

55.65
1.85%

Conference Call with Vascon Engineers Management and Analysts on Q4FY22 Performance and Outlook. Click pdf to read the full concall transcript.

1260.90
0.82%
ICICI Securities Ltd - 541179 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the management of the Company had a con-call with Investors and Analysts on June 27, 2022. The business presentation has been uploaded on the website of the Company i.e. https://www.icicisecurities.com/. Please find enclosed the schedule of Investor and Analyst Meets. Kindly take the above on your records and oblige.

Earnings Calls Podcast on